Sun Pharmaceutical Industries Limited (SUNPHARMA.BO)
INR 1688.75
(1.22%)
INR 1688.75
(1.22%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 138.36 Billion INR | 5.75% |
| 2022 | 120.84 Billion INR | 8.5% |
| 2021 | 66.99 Billion INR | 25.02% |
| 2020 | 49.98 Billion INR | 20.47% |
| 2019 | 73.12 Billion INR | 4.47% |
| 2018 | 60.84 Billion INR | 16.81% |
| 2017 | 54.03 Billion INR | -41.93% |
| 2016 | 106.72 Billion INR | 24.72% |
| 2015 | 80.77 Billion INR | 4.27% |
| 2014 | 81.76 Billion INR | 8.33% |
| 2013 | 50.36 Billion INR | 42.81% |
| 2012 | 46.94 Billion INR | 43.21% |
| 2011 | 36.75 Billion INR | 58.87% |
| 2010 | 23.17 Billion INR | 47.76% |
| 2009 | 15.68 Billion INR | -24.33% |
| 2008 | 20.72 Billion INR | 22.18% |
| 2007 | 16.96 Billion INR | 85.42% |
| 2006 | 9.14 Billion INR | 39.04% |
| 2005 | 6.57 Billion INR | 42.56% |
| 2004 | 4.61 Billion INR | 12.62% |
| 2003 | 4.09 Billion INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 42.92 Billion INR | 3.69% |
| 2024 Q1 | 36.58 Billion INR | 16.97% |
| 2023 Q1 | 35.36 Billion INR | 11.36% |
| 2023 Q4 | 30.91 Billion INR | -17.05% |
| 2023 Q3 | 37.27 Billion INR | 7.31% |
| 2023 Q2 | 34.72 Billion INR | -1.79% |
| 2023 FY | - INR | 5.75% |
| 2022 Q1 | 28.86 Billion INR | 5.53% |
| 2022 Q4 | 31.75 Billion INR | -0.07% |
| 2022 FY | - INR | 8.5% |
| 2022 Q2 | 30.41 Billion INR | 5.38% |
| 2022 Q3 | 31.77 Billion INR | 4.47% |
| 2021 Q4 | 27.35 Billion INR | -9.99% |
| 2021 FY | - INR | 25.02% |
| 2021 Q1 | 29.73 Billion INR | 57.63% |
| 2021 Q3 | 30.38 Billion INR | 6.52% |
| 2021 Q2 | 28.52 Billion INR | -4.06% |
| 2020 Q1 | 19.97 Billion INR | 47.38% |
| 2020 Q2 | 24.49 Billion INR | 22.62% |
| 2020 Q3 | 27.21 Billion INR | 11.11% |
| 2020 Q4 | 18.86 Billion INR | -30.67% |
| 2020 FY | - INR | 20.47% |
| 2019 Q2 | 19.9 Billion INR | -9.87% |
| 2019 Q1 | 22.08 Billion INR | 90.53% |
| 2019 Q3 | 19.61 Billion INR | -1.47% |
| 2019 Q4 | 13.55 Billion INR | -30.9% |
| 2019 FY | - INR | 4.47% |
| 2018 Q2 | 18.82 Billion INR | 4.2% |
| 2018 FY | - INR | 16.81% |
| 2018 Q1 | 18.06 Billion INR | -9.05% |
| 2018 Q4 | 11.59 Billion INR | -50.59% |
| 2018 Q3 | 23.45 Billion INR | 24.63% |
| 2017 Q3 | 15.82 Billion INR | -2.94% |
| 2017 Q2 | 16.3 Billion INR | 30.68% |
| 2017 FY | - INR | -41.93% |
| 2017 Q1 | 12.47 Billion INR | -29.59% |
| 2017 Q4 | 19.86 Billion INR | 25.51% |
| 2016 Q3 | 25.75 Billion INR | -21.65% |
| 2016 Q1 | 30.78 Billion INR | 24.22% |
| 2016 Q4 | 17.71 Billion INR | -31.19% |
| 2016 Q2 | 32.87 Billion INR | 6.79% |
| 2016 FY | - INR | 24.72% |
| 2015 FY | - INR | 4.27% |
| 2015 Q1 | 19.31 Billion INR | 62.71% |
| 2015 Q4 | 24.77 Billion INR | 2.45% |
| 2015 Q3 | 24.18 Billion INR | 21.65% |
| 2015 Q2 | 19.88 Billion INR | 2.91% |
| 2014 Q4 | 11.87 Billion INR | -43.13% |
| 2014 Q3 | 20.87 Billion INR | -31.21% |
| 2014 FY | - INR | 8.33% |
| 2014 Q1 | 21.2 Billion INR | 16.25% |
| 2014 Q2 | 30.35 Billion INR | 43.17% |
| 2013 Q1 | 16.26 Billion INR | 18.69% |
| 2013 FY | - INR | 42.81% |
| 2013 Q4 | 18.23 Billion INR | -14.59% |
| 2013 Q3 | 21.35 Billion INR | 9.62% |
| 2013 Q2 | 19.47 Billion INR | 19.8% |
| 2012 Q3 | 12.61 Billion INR | -6.2% |
| 2012 Q2 | 13.44 Billion INR | 10.65% |
| 2012 Q1 | 12.14 Billion INR | 2.88% |
| 2012 FY | - INR | 43.21% |
| 2012 Q4 | 13.69 Billion INR | 8.64% |
| 2011 Q4 | 11.8 Billion INR | 22.53% |
| 2011 Q3 | 9.63 Billion INR | 5.93% |
| 2011 FY | - INR | 58.87% |
| 2011 Q2 | 9.09 Billion INR | 38.29% |
| 2011 Q1 | 6.57 Billion INR | 0.0% |
| 2010 FY | - INR | 47.76% |
| 2009 FY | - INR | -24.33% |
| 2008 FY | - INR | 22.18% |
| 2007 FY | - INR | 85.42% |
| 2006 FY | - INR | 39.04% |
| 2005 FY | - INR | 42.56% |
| 2004 FY | - INR | 12.62% |
| 2003 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 9.61 Billion INR | -1338.781% |
| Aurobindo Pharma Limited | 61.78 Billion INR | -123.933% |
| Glenmark Life Sciences Limited | 6.86 Billion INR | -1916.111% |
| Granules India Limited | 8.6 Billion INR | -1508.161% |
| Indoco Remedies Limited | 2.64 Billion INR | -5127.068% |
| Achyut Healthcare Limited | 524 Thousand INR | -26405109.924% |
| Ajanta Pharma Limited | 12.56 Billion INR | -1001.145% |
| Alkem Laboratories Limited | 24.19 Billion INR | -471.865% |
| Alpa Laboratories Limited | 86.12 Million INR | -160550.319% |
| Brooks Laboratories Limited | 41.72 Million INR | -331483.829% |
| AstraZeneca Pharma India Limited | 2.35 Billion INR | -5770.812% |
| Bajaj HealthCare Limited | 444.51 Million INR | -31026.731% |
| Bliss GVS Pharma Limited | 1.47 Billion INR | -9255.003% |
| Dr. Reddy's Laboratories Limited | 88.27 Billion INR | -56.741% |
| Eris Lifesciences Limited | 6.98 Billion INR | -1880.452% |
| FDC Limited | 4.4 Billion INR | -3043.415% |
| Glenmark Pharmaceuticals Limited | 11.34 Billion INR | -1119.737% |
| Gufic Biosciences Limited | 1.48 Billion INR | -9245.803% |
| Ind-Swift Laboratories Limited | 6.86 Billion INR | -1916.477% |
| Ipca Laboratories Limited | 13.29 Billion INR | -940.365% |
| Jagsonpal Pharmaceuticals Limited | 323.46 Million INR | -42676.016% |
| Krebs Biochemicals & Industries Limited | -82.72 Million INR | 167352.892% |
| Lasa Supergenerics Limited | -65.08 Million INR | 212704.948% |
| Laurus Labs Limited | 8 Billion INR | -1628.245% |
| Lupin Limited | 36.96 Billion INR | -274.264% |
| Mankind Pharma Limited | 28.09 Billion INR | -392.49% |
| Medicamen Biotech Limited | 245.66 Million INR | -56223.089% |
| Medico Remedies Limited | 150.37 Million INR | -91910.334% |
| Megasoft Limited | 284.73 Million INR | -48494.393% |
| NATCO Pharma Limited | 18.79 Billion INR | -636.171% |
| Piramal Pharma Limited | 13.05 Billion INR | -959.817% |
| RPG Life Sciences Limited | 1.28 Billion INR | -10696.98% |
| Sigachi Industries Limited | 883.39 Million INR | -15562.623% |
| Suven Pharmaceuticals Limited | 4.67 Billion INR | -2858.262% |
| Syncom Formulations (India) Limited | 430.27 Million INR | -32056.871% |
| Unichem Laboratories Limited | 742.35 Million INR | -18538.403% |
| Wanbury Limited | 985.49 Million INR | -13940.051% |
| Windlas Biotech Limited | 781.72 Million INR | -17599.854% |
| ZIM Laboratories Limited | 462.09 Million INR | -29842.48% |
| Zydus Lifesciences Limited | 56.22 Billion INR | -146.102% |
| Sun Pharma Advanced Research Company Limited | -3.73 Billion INR | 3808.211% |
| Divi's Laboratories Limited | 25.43 Billion INR | -444.095% |
| Hester Biosciences Limited | 539.47 Million INR | -25548.006% |
| Procter & Gamble Health Limited | 3.01 Billion INR | -4490.078% |
| Amrutanjan Health Care Limited | 682.53 Million INR | -20171.882% |
| Bal Pharma Limited | 345.59 Million INR | -39936.604% |
| Strides Pharma Science Limited | 3.76 Billion INR | -3575.3% |
| Venus Remedies Limited | 711.8 Million INR | -19338.481% |
| Aarti Pharmalabs Limited | 3.9 Billion INR | -3439.229% |
| Nectar Lifesciences Limited | 1.56 Billion INR | -8747.946% |
| Shilpa Medicare Limited | 2.58 Billion INR | -5246.376% |
| Aarti Drugs Limited | 3.24 Billion INR | -4159.128% |
| IOL Chemicals and Pharmaceuticals Limited | 2.6 Billion INR | -5208.191% |
| Suven Life Sciences Limited | -992.78 Million INR | 14036.955% |
| Ind-Swift Limited | 1.06 Billion INR | -12891.054% |
| Valiant Laboratories Limited | 12.73 Million INR | -1086039.414% |
| J. B. Chemicals & Pharmaceuticals Limited | 9.33 Billion INR | -1382.229% |
| Solara Active Pharma Sciences Limited | -2.82 Billion INR | 5003.196% |
| Themis Medicare Limited | 562.6 Million INR | -24493.242% |
| Hikal Limited | 2.69 Billion INR | -5039.357% |
| Torrent Pharmaceuticals Limited | 35 Billion INR | -295.214% |
| Sequent Scientific Limited | 549.8 Million INR | -25066.115% |
| Novartis India Limited | 1.26 Billion INR | -10800.756% |
| Wockhardt Limited | 1.08 Billion INR | -12711.417% |
| Jubilant Pharmova Limited | 8 Billion INR | -1628.245% |
| Biofil Chemicals and Pharmaceuticals Limited | 13.06 Million INR | -1059181.121% |
| Neuland Laboratories Limited | 4.74 Billion INR | -2814.026% |
| Morepen Laboratories Limited | 1.72 Billion INR | -7916.627% |
| Kilitch Drugs (India) Limited | 287.42 Million INR | -48038.923% |
| Mangalam Drugs & Organics Limited | 174.94 Million INR | -78989.148% |